Literature DB >> 35380695

Sequence and tissue targeting specificity of ZFP36L2 reveals Elavl2 as a novel target with co-regulation potential.

Ian C Redmon1, Matthew Ardizzone1, Hilal Hekimoğlu1, Breanne M Hatfield2, Justin M Waldern3, Abhishek Dey3, Stephanie A Montgomery4, Alain Laederach3,5, Silvia B V Ramos1.   

Abstract

Zinc finger protein 36 like 2 (ZFP36L2) is an RNA-binding protein that destabilizes transcripts containing adenine-uridine rich elements (AREs). The overlap between ZFP36L2 targets in different tissues is minimal, suggesting that ZFP36L2-targeting is highly tissue specific. We developed a novel Zfp36l2-lacking mouse model (L2-fKO) to identify factors governing this tissue specificity. We found 549 upregulated genes in the L2-fKO spleen by RNA-seq. These upregulated genes were enriched in ARE motifs in the 3'UTRs, which suggests that they are ZFP36L2 targets, however the precise sequence requirement for targeting was not evident from motif analysis alone. We therefore used gel-shift mobility assays on 12 novel putative targets and established that ZFP36L2 requires a 7-mer (UAUUUAU) motif to bind. We observed a statistically significant enrichment of 7-mer ARE motifs in upregulated genes and determined that ZFP36L2 targets are enriched for multiple 7-mer motifs. Elavl2 mRNA, which has three 7-mer (UAUUUAU) motifs, was also upregulated in L2-fKO spleens. Overexpression of ZFP36L2, but not a ZFP36L2(C176S) mutant, reduced Elavl2 mRNA expression, suggesting a direct negative effect. Additionally, a reporter assay demonstrated that the ZFP36L2 effect on Elavl2 decay is dependent on the Elavl2-3'UTR and requires the 7-mer AREs. Our data indicate that Elavl2 mRNA is a novel target of ZFP36L2, specific to the spleen. Likely, ZFP36L2 combined with other RNA binding proteins, such as ELAVL2, governs tissue specificity.
© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35380695      PMCID: PMC9023260          DOI: 10.1093/nar/gkac209

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   19.160


  52 in total

Review 1.  The highways and byways of mRNA decay.

Authors:  Nicole L Garneau; Jeffrey Wilusz; Carol J Wilusz
Journal:  Nat Rev Mol Cell Biol       Date:  2007-02       Impact factor: 94.444

2.  Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia.

Authors:  Daniel J Hodson; Michelle L Janas; Alison Galloway; Sarah E Bell; Simon Andrews; Cheuk M Li; Richard Pannell; Christian W Siebel; H Robson MacDonald; Kim De Keersmaecker; Adolfo A Ferrando; Gerald Grutz; Martin Turner
Journal:  Nat Immunol       Date:  2010-07-11       Impact factor: 25.606

3.  Differential effects of sodium butyrate on the transcription of the human TIS11 family of early-response genes in colorectal cancer cells.

Authors:  K N Maclean; I A McKay; S A Bustin
Journal:  Br J Biomed Sci       Date:  1998-09       Impact factor: 3.829

4.  Translational repression of pre-formed cytokine-encoding mRNA prevents chronic activation of memory T cells.

Authors:  Fiamma Salerno; Sander Engels; Maartje van den Biggelaar; Floris P J van Alphen; Aurelie Guislain; Wanqi Zhao; Deborah L Hodge; Sarah E Bell; Jan Paul Medema; Marieke von Lindern; Martin Turner; Howard A Young; Monika C Wolkers
Journal:  Nat Immunol       Date:  2018-07-09       Impact factor: 25.606

5.  An RNA binding protein promotes axonal integrity in peripheral neurons by destabilizing REST.

Authors:  Francesca Cargnin; Tamilla Nechiporuk; Karin Müllendorff; Deborah J Stumpo; Perry J Blackshear; Nurit Ballas; Gail Mandel
Journal:  J Neurosci       Date:  2014-12-10       Impact factor: 6.167

6.  ERF-2, the human homologue of the murine Tis11d early response gene.

Authors:  X F Nie; K N Maclean; V Kumar; I A McKay; S A Bustin
Journal:  Gene       Date:  1995-01-23       Impact factor: 3.688

7.  ELAVL2-directed RNA regulatory network drives the formation of quiescent primordial follicles.

Authors:  Yuzuru Kato; Tokuko Iwamori; Youichirou Ninomiya; Takashi Kohda; Jyunko Miyashita; Mikiko Sato; Yumiko Saga
Journal:  EMBO Rep       Date:  2019-10-28       Impact factor: 8.807

8.  Functional regulation of Zfp36l1 and Zfp36l2 in response to lipopolysaccharide in mouse RAW264.7 macrophages.

Authors:  Kuan-Ting Wang; Hsin-Hui Wang; Yan-Yun Wu; Yu-Lun Su; Pei-Yu Chiang; Nien-Yi Lin; Shun-Chang Wang; Geen-Dong Chang; Ching-Jin Chang
Journal:  J Inflamm (Lond)       Date:  2015-07-16       Impact factor: 4.981

9.  Impact of RNA structure on ZFP36L2 interaction with luteinizing hormone receptor mRNA.

Authors:  Christopher B Ball; Amanda C Solem; Rita M Meganck; Alain Laederach; Silvia B V Ramos
Journal:  RNA       Date:  2017-04-28       Impact factor: 4.942

10.  RNA-Binding Protein ZFP36L2 Downregulates Helios Expression and Suppresses the Function of Regulatory T Cells.

Authors:  Sohei Makita; Hiroaki Takatori; Arifumi Iwata; Shigeru Tanaka; Shunsuke Furuta; Kei Ikeda; Akira Suto; Kotaro Suzuki; Silvia B V Ramos; Hiroshi Nakajima
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.